I'm a Data Analyst, researcher and statistics enthusiast. This story contains new, firsthand information uncovered by the writer. Story's Credibility AI-assisted This story contains AI-generated text.

The Python extension now supports multi-project workspaces, where each Python project within a workspace gets its own test tree and Python environment. This document explains how multi-project testing ...

James and I worked at Villanova University together for 6 years. I am still in touch with him. Ijames, 46, was born in North Carolina and attended Morehouse College in Atlanta, Georgia. He earned his ...

Abstract: The proliferation of web automation testing tools presents a significant challenge for developers and QA engineers in selecting the most suitable solution. This study provides a systematic ...

Playwright’s `storageState` feature captures the complete browser authentication context—cookies, localStorage, sessionStorage, and IndexedDB—in a single JSON file. This isn’t just cookie management; ...

In this talk, Jaswanth Manigundan shares a practical view of how AI and the Playwright MCP server can support day to day web testing. He draws on his experience as a tester, automation engineer, and ...

I have been struggling to write a tribute to Tom Stoppard, the living playwright I admired more than any other in my professional life as a theater critic. Why was he my favorite? Whereas most ...

"I'm not some kind of intellectual who's importing very special ideas into the unfamiliar terrain of the theater. I don't see it like that at all," he said. "There's something about the way the plays ...

This is read by an automated voice. Please report any issues or inconsistencies here. Tom Stoppard, acclaimed Czech-born British playwright and Oscar-winning screenwriter, dies at 88 in his Dorset ...

LONDON (AP) — British playwright Tom Stoppard, a playful, probing dramatist who won an Academy Award for the screenplay for 1998’s “Shakespeare In Love,” has died. He was 88. In a statement Saturday, ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...